DEVeloping NOVEL DRUGS TO TREAT AMYLOID DISEASES

ADRx, Inc.

ADRx, Inc. is a biopharmaceutical company created to develop first-in-class and best-in-class drugs for amyloid diseases. The company intends to discover and develop drug candidates independently and in partnership with pharmaceutical and biotechnology companies.  

Brain section of an Alzheimer's patient with amyloid plaques stained in red (left).  A close up of amyloid fibers of an isolated protein (right).

Our Company

Technology

 

ADRx technology utilizes ground-breaking atomic-level structural understanding of amyloids enabling discovery and development of therapeutics to treat amyloid diseases.


Amyloid Disease

 
Many human diseases, including Alzheimer's, Type II Diabetes, and cancer, share a common characteristic of abnormal deposits of protein (termed amyloid) which can damage various tissues and organs causing and promoting disease onset and disease progression.